| アブストラクト | BACKGROUND: We evaluated the association between nifekalant or amiodarone on hospital admission and in-hospital mortality for cardiac arrest patients with persistent ventricular fibrillation on hospital arrival. METHODS: This was a retrospective cohort study using the Japanese Diagnosis Procedure Combination inpatient database. We identified 2961 patients who suffered cardiogenic out-of-hospital cardiac arrest and who had ventricular fibrillation on hospital arrival between July 2007 and March 2013. Patients were categorized into amiodarone (n=2353) and nifekalant (n=608) groups, from which 525 propensity score-matched pairs were generated. RESULTS: We found a significant difference in the admission rate between the nifekalant and amiodarone groups in propensity score-matched groups (75.6% vs. 69.3%, respectively; difference, 6.3%; 95% confidence interval (CI), 0.9-11.7). An analysis using the hospital nifekalant/amiodarone rate as an instrumental variable found that receiving nifekalant was associated with an improved admission rate (22.2%, 95% CI, 11.9-32.4). We found no significant difference in in-hospital mortality between the nifekalant and amiodarone groups (81.5% vs. 82.1%, respectively; difference, -0.6%; 95% CI, -5.2 to 4.1). Instrumental variable analysis showed that receiving nifekalant was not associated with reduced in-hospital mortality (6.2%, 95% CI, -2.4 to 14.8). CONCLUSIONS: This nationwide study suggested no significant in-hospital mortality association between nifekalant and amiodarone for cardiogenic out-of-hospital cardiac arrest patients with ventricular fibrillation/persistent ventricular tachycardia on hospital arrival. Although nifekalant may potentially improve hospital admission rates compared with amiodarone for these patients, further studies are required to confirm our results. |
|---|
| ジャーナル名 | Resuscitation |
|---|
| 投稿日 | 2016/08/29 |
|---|
| 投稿者 | Tagami, Takashi; Matsui, Hiroki; Ishinokami, Saori; Oyanagi, Masao; Kitahashi, Akiko; Fukuda, Reo; Unemoto, Kyoko; Fushimi, Kiyohide; Yasunaga, Hideo |
|---|
| 組織名 | Department of Clinical Epidemiology and Health Economics, School of Public;Health, Graduate School of Medicine, The University of Tokyo, Japan; Department;of Emergency and Critical Care Medicine, Nippon Medical School Tama Nagayama;Hospital, Japan. Electronic address: t-tagami@nms.ac.jp.;Health, Graduate School of Medicine, The University of Tokyo, Japan.;Department of Emergency and Critical Care Medicine, Nippon Medical School Tama;Nagayama Hospital, Japan.;Department of Health Informatics and Policy, Tokyo Medical and Dental University,;Graduate School of Medicine, Japan. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/27568110/ |
|---|
